What vaccines against COVID-19 are purchased in the world and who are the main buyers – infographic LIGA.net
The best-selling vaccine in the world right now is from AstraZeneca and the University of Oxford. A total of 2.965 billion doses have been ordered.
In second and third place are vaccines from Novavax (1.284 billion doses) and Pfizer / BioNTech (816 million doses). India has the largest number of orders for vaccines against coronavirus – 3 billion doses, of which 1 billion is the Russian drug Sputnik V.
Vaccine from the center. Gamaleya and the RF Ministry of Defense “Sputnik V” is based on two human adenoviruses (caused by one of the common cold viruses): they were genetically engineered with protein spikes from SARS CoV-2. The developers assure (without publication in reputable scientific publications) that “the vaccine has been tested more than” and its effect “will last a couple of years”, and that “Pfizer, Moderna and AstraZeneca are following our principle.” Meanwhile, they failed phase III trials (the main one, the positive results of which and the subsequent approval of regulators, including WHO, give the candidate the right to be called a vaccine), they failed: people from the placebo group began to be massively vaccinated with an already available drug. Thus, it is no longer possible to obtain final data on the effectiveness of the drug – at least in the Russian Federation.
Under the COVAX program of the World Health Organization, 410 million doses of vaccines have already been purchased, including AstraZeneca / Oxford (300 million) and Sanofi / GSK (110 million).
Earlier, on November 19, 2020, it was reported that COVAX will provide Ukraine with 8 million doses of vaccines against coronavirus disease. Later, the Minister of the Cabinet of Ministers Oleg Nemchinov said that Ukraine could receive 16 million doses.
The World Health Organization’s COVAX program is a global human coronavirus vaccination scheme in low- and middle-income countries. It aims to deliver at least 2 billion doses of vaccine by the end of 2021 to reach 20% of the most vulnerable in 91 low- and middle-income countries, mainly in Africa, Asia and Latin America. Currently, there is no information about which vaccines will participate in the program.
In addition to Ukraine, contracts for the supply of vaccines from Sinovac were also signed by Indonesia (50 million), Turkey (50 million) and Brazil (46 million). Other countries, including Ukraine, have ordered 28 million doses of vaccinations.